Carrie McAdam Marx, MSCI, PhD, RPh, is an Associate Professor and Director of the Pharmaceutical Evaluation & Policy Division (PEP) in the UAMS College of Pharmacy. Dr. McAdam-Marx’s overarching academic goal is to generate evidence to support policy-relevant decisions in pharmacotherapy. She is also dedicated to developing the next generation of researchers to advance this area of science and health policy. Her research scope includes real-world outcomes studies to demonstrate the effectiveness of drug therapies when used in a usual practice setting, primarily for diabetes. She also leads studies to assess the effectiveness, value, and feasibility of clinical pharmacist-led comprehensive medication management in the primary care setting. Dr. McAdam-Marx’s teaching has included US Healthcare Systems and Policy, Managed Care Pharmacy, and Introductory Statistics for PharmD Students, in addition to advising and mentoring graduate students. Prior to joining UAMS, she was an Associate Professor & Director of Graduate Studies with the Department of Pharmacotherapy & Pharmacotherapy Outcomes Research Center at the University of Utah. Prior to joining academia, Dr. McAdam-Marx had an established career in the managed care and pharmaceutical industries where she led the development and delivery of disease management and appropriate use of medicines programs, and managed drug pricing and payer contracting strategies. Dr. McAdam Marx has a BS in Pharmacy from the University of Kansas, an MS in Hospital Pharmacy from the University of Minnesota, and a PhD in Health Policy from the University of the Sciences Philadelphia. She also has a Master of Science in Clinical Investigation (MSCI) from the University of Utah as part of a NIH-sponsored KM1 Career Development Program in Translational Comparative Effectiveness Research (CER).